Viewing Study NCT01257594


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-02-13 @ 4:50 AM
Study NCT ID: NCT01257594
Status: COMPLETED
Last Update Posted: 2023-05-25
First Post: 2010-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas
Sponsor: Andrew B Lassman, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gliomas View
None Erlotinib View
None Glioblastoma View
None GBM View
None Gliosarcoma View
None Glioma View